ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sloan
|
10K |
4.9M |
34 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
10K
|
4.9M
|
34
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sloan
|
10K |
4.9M |
36 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
10K
|
4.9M
|
36
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sloan
|
10K |
4.9M |
4 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
10K
|
4.9M
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
Sloan
|
121 |
54K |
4 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
121
|
54K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 8 November 2023
|
|
Sloan
|
22 |
12K |
5 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
22
|
12K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sloan
|
10K |
4.9M |
22 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
10K
|
4.9M
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sloan
|
10K |
4.9M |
5 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
10K
|
4.9M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Media News
|
|
Sloan
|
221 |
97K |
3 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
221
|
97K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Media News
|
|
Sloan
|
221 |
97K |
5 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
221
|
97K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Sloan
|
677 |
325K |
3 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
677
|
325K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sloan
|
10K |
4.9M |
25 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
10K
|
4.9M
|
25
|
|
ASX - By Stock
|
PEB |
Re:
Ann: Clarification of Novitas Timeline
|
|
Sloan
|
9 |
3.4K |
0 |
04/06/23 |
04/06/23 |
ASX - By Stock
|
9
|
3.4K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Pending ROW deal??
|
|
Sloan
|
227 |
104K |
41 |
01/04/23 |
01/04/23 |
ASX - By Stock
|
227
|
104K
|
41
|
|
ASX - By Stock
|
NEU |
Re:
FDA
|
|
Sloan
|
122 |
47K |
10 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
122
|
47K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
FDA
|
|
Sloan
|
122 |
47K |
28 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
122
|
47K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sloan
|
10K |
4.9M |
35 |
04/12/22 |
04/12/22 |
ASX - By Stock
|
10K
|
4.9M
|
35
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sloan
|
10K |
4.9M |
0 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
10K
|
4.9M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sloan
|
10K |
4.9M |
3 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
10K
|
4.9M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Nearly at the bottom?
|
|
Sloan
|
138 |
69K |
10 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
138
|
69K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: New patent issued to 2032 for Neuren's trofinetide in Canada
|
|
Sloan
|
14 |
7.7K |
14 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
14
|
7.7K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
ACADIA earnings
|
|
Sloan
|
112 |
54K |
10 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
112
|
54K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren corporate presentation, 24 February 2021
|
|
Sloan
|
42 |
18K |
3 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
42
|
18K
|
3
|
|
ASX - By Stock
|
PEB |
Re:
no news
|
|
Sloan
|
7 |
1.7K |
0 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
7
|
1.7K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
patent USA 2591
|
|
Sloan
|
16 |
11K |
7 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
16
|
11K
|
7
|
|